Insight Molecular Diagnostics Inc (0KCC.L)

Healthcare | Medical Pharmaceuticals
Income Statement (Quarterly) 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue 260,000 518,000 2,138,000 1,486,000
Cost of Revenue 121,000 168,000 813,000 891,000
Gross Profit 139,000 350,000 1,325,000 595,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 3,931,000 4,107,000 4,321,000 3,398,000
Operating Expenses 11,187,000 10,192,000 8,124,000 34,222,000
Operating Income -11,048,000 -9,842,000 -6,799,000 -33,627,000
Interest Expense 29,000 25,000 29,000 30,000
Income Before Tax -10,854,000 -9,742,000 -6,671,000 -33,511,000
Income Tax Expense 0 0 0 0
Net Income -10,854,000 -9,742,000 -6,671,000 -33,511,000
Per Share
EPS -0.34 -0.30 -0.26 -1.93
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Revenue 1,881,000 1,503,000 958,000
Cost of Revenue 1,141,000 1,090,000 6,196,000
Gross Profit 740,000 413,000 -5,238,000
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 13,785,000 13,536,000 16,628,000
Operating Expenses 61,781,000 25,637,000 23,593,000
Operating Income -61,041,000 -25,136,000 -28,831,000
Interest Expense 84,000 52,000 77,000
Income Before Tax -60,663,000 -24,855,000 -18,612,000
Income Tax Expense 0 0 520,000
Net Income -60,663,000 -27,781,000 -72,902,000
Per Share
EPS -4.66 -3.75 -13.16
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 8,636,000 9,432,000 19,993,000
Short Term Investments 0 0 433,000
Net Receivables 1,613,000 484,000 2,012,000
Inventory 410,000 0 0
Total Current Assets 11,759,000 10,698,000 25,536,000
Property Plant Equipment 2,757,000 5,436,000 10,851,000
Goodwill and Intangibles 14,607,000 56,595,000 61,633,000
Total Assets 35,081,000 74,892,000 100,091,000
Liabilities
Account Payables 2,279,000 953,000 1,253,000
Short Term Debt 1,295,000 665,000 815,000
Total Current Liabilities 7,275,000 7,194,000 12,106,000
Long Term Debt 2,369,000 2,204,000 0
Total Liabilities 47,355,000 49,298,000 60,497,000
Shareholders Equity
Retained Earnings -350,539,000 -289,876,000 -260,676,000
Total Shareholders Equity -12,274,000 25,594,000 39,594,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 8,636,000 9,432,000 19,993,000
Short Term Investments 0 0 433,000
Net Receivables 1,613,000 484,000 2,012,000
Inventory 410,000 0 0
Total Current Assets 11,759,000 10,698,000 25,536,000
Property Plant Equipment 2,757,000 5,436,000 10,851,000
Goodwill and Intangibles 14,607,000 56,595,000 61,633,000
Total Assets 35,081,000 74,892,000 100,091,000
Liabilities
Account Payables 2,279,000 953,000 1,253,000
Short Term Debt 1,295,000 665,000 815,000
Total Current Liabilities 7,275,000 7,194,000 12,106,000
Long Term Debt 2,369,000 2,204,000 0
Total Liabilities 47,355,000 49,298,000 60,497,000
Shareholders Equity
Retained Earnings -350,539,000 -289,876,000 -260,676,000
Total Shareholders Equity -12,274,000 25,594,000 39,594,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income -60,663,000 -27,781,000 -18,612,000
Depreciation & Amortization 1,564,000 1,680,000 5,220,000
Stock Based Compensation 1,913,000 6,573,000 6,479,000
Change in Working Capital -1,321,000 -3,971,000 -1,942,000
Operating Cash Flow -20,713,000 -23,325,000 -45,568,000
Investing Activities
Capital Expenditure -516,000 -281,000 -4,340,000
Investments -516,000 -281,000 -4,340,000
Investing Cash Flow -512,000 -932,000 -4,340,000
Financing Activities
Debt Repayment -201,000 -117,000 -1,429,000
Common Stock Issued/Repurchased 27,814,000 12,730,000 37,236,000
Dividends Paid 0 0 0
Financing Cash Flow 20,429,000 12,186,000 35,806,000
Summary
Free Cash Flow -21,229,000 -23,606,000 -49,908,000
Net Change in Cash -796,000 -12,071,000 -12,955,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income -60,663,000 -27,781,000 -18,612,000
Depreciation & Amortization 1,564,000 1,680,000 5,220,000
Stock Based Compensation 1,913,000 6,573,000 6,479,000
Change in Working Capital -1,321,000 -3,971,000 -1,942,000
Operating Cash Flow -20,713,000 -23,325,000 -45,568,000
Investing Activities
Capital Expenditure -516,000 -281,000 -4,340,000
Investments -516,000 -281,000 -4,340,000
Investing Cash Flow -512,000 -932,000 -4,340,000
Financing Activities
Debt Repayment -201,000 -117,000 -1,429,000
Common Stock Issued/Repurchased 27,814,000 12,730,000 37,236,000
Dividends Paid 0 0 0
Financing Cash Flow 20,429,000 12,186,000 35,806,000
Summary
Free Cash Flow -21,229,000 -23,606,000 -49,908,000
Net Change in Cash -796,000 -12,071,000 -12,955,000